Entral Feeding in Acute Severe Pancreatitis
কীওয়ার্ডস
বিমূর্ত
বর্ণনা
- The study was conducted on monitoring of four pillar for 13 days (data collected one day before feeding and every three days for 12 days). the first pillar comparing the effect of the two enteral feeding methods on the clinical condition of the acute severe pancreatitis and this monitored clinically and laboratory by fixed parameters, clinically, by abdominal pain which assessed by visual analogue scale (VAS). and laboratory, by both markers of severity of pancreatic acini destruction which assessed by serum amylase, lipase and Markers of severity of interstitial pancreatic tissue destruction which assessed by the level of Lactate Dehydrogenase level (LDH), Aspartate aminotransferase (AST), C-reactive protein, prostacyclin and interleukin 8. The second pillar include effect of the two enteral feeding methods on the patient's tolerance and these monitored in our study by both post-feeding vomiting and post feeding attacks of osmotic diarrhea and also abdominal pain. Third pillar include effect of the two enteral feeding methods on the patient's general condition and these monitored by follows the APACHE II Score, hemodynamics of the patients in both groups (Mean arterial blood pressure and pulse) and arterial oxygen saturation (Spo2). Fourth pillar include effect of the two enteral feeding methods on achieving satisfactory nutrition parameters of the patients and both albumin level, radium blood sugar and electrolytes (sodium and potassium level) used as indicator for this.
- All parameters observed one day before starting feeding and every 3 days for 12 days (duration of the study).
তারিখ
সর্বশেষ যাচাই করা হয়েছে: | 04/30/2020 |
প্রথম জমা দেওয়া: | 05/20/2020 |
আনুমানিক তালিকাভুক্তি জমা দেওয়া হয়েছে: | 05/26/2020 |
প্রথম পোস্ট: | 05/27/2020 |
সর্বশেষ আপডেট জমা দেওয়া হয়েছে: | 05/26/2020 |
সর্বশেষ আপডেট পোস্ট: | 05/27/2020 |
আসল অধ্যয়ন শুরুর তারিখ: | 06/09/2018 |
আনুমানিক প্রাথমিক সমাপ্তির তারিখ: | 04/01/2020 |
আনুমানিক অধ্যয়ন সমাপ্তির তারিখ: | 04/09/2020 |
অবস্থা বা রোগ
হস্তক্ষেপ / চিকিত্সা
Device: Group A
Device: Group B
Drug: (erythromycin 250 mg IV bolus)
পর্যায়
বাহু গ্রুপ
বাহু | হস্তক্ষেপ / চিকিত্সা |
---|---|
Group A Group A received nasogastric feeding (NG), insure through ngt pump | Device: Group A • The insertion of NG tubes were performed by the ICU physician and the position was checked by auscultation of gas from 50 ml syringe by injecting 20 ml of air in the NG and by X-ray abdomen to be sure from the site of NG tube |
Group B receive feeding throughThe nasojejunal tube is silicone or polyurethane tube with an inner stylet that is positioned (under fluoroscopic guidance) beyond the ligament of Treitz.
Patients were placed in right lateral position | Device: Group B The nasojejunal tube is silicone or polyurethane tube with an inner stylet that is positioned (under fluoroscopic guidance) beyond the ligament of Treitz.
Patients were placed in right lateral position |
যোগ্যতার মানদণ্ড
বয়স অধ্যয়নের জন্য যোগ্য | 18 Years প্রতি 18 Years |
লিঙ্গ অধ্যয়নের জন্য যোগ্য | All |
নমুনা পদ্ধতি | Probability Sample |
স্বাস্থ্যকর স্বেচ্ছাসেবীদের গ্রহণ করে | না |
নির্ণায়ক | Inclusion Criteria: - acute pancreatitis Exclusion Criteria: - systemic disease as hypertension or diabetes |
ফলাফল
প্রাথমিক ফলাফল ব্যবস্থা
1. effect of different methods of feeding in the clinical condition of the acute severe pancreatitis [13 days]